ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,293,712 | +4.9% | 24,495 | 0.0% | 0.99% | +4.7% |
| Q2 2023 | $2,186,179 | -21.6% | 24,495 | -5.9% | 0.95% | -19.7% |
| Q1 2023 | $2,789,543 | -12.2% | 26,017 | -0.0% | 1.18% | -23.1% |
| Q4 2022 | $3,178,189 | +18.3% | 26,023 | 0.0% | 1.54% | +2.5% |
| Q3 2022 | $2,687,000 | +23.9% | 26,023 | +11.6% | 1.50% | +38.1% |
| Q2 2022 | $2,168,000 | -37.8% | 23,322 | -21.5% | 1.08% | -21.1% |
| Q1 2022 | $3,488,000 | -29.7% | 29,722 | -19.5% | 1.38% | -10.1% |
| Q4 2021 | $4,964,000 | -15.6% | 36,899 | 0.0% | 1.53% | -17.5% |
| Q3 2021 | $5,881,000 | +25.8% | 36,899 | +3.8% | 1.85% | +38.6% |
| Q2 2021 | $4,676,000 | +2.3% | 35,544 | +0.2% | 1.34% | -3.0% |
| Q1 2021 | $4,573,000 | -29.3% | 35,484 | -8.5% | 1.38% | -38.9% |
| Q4 2020 | $6,468,000 | +8.1% | 38,783 | 0.0% | 2.26% | -7.7% |
| Q3 2020 | $5,985,000 | +4.3% | 38,783 | +0.0% | 2.44% | +1.8% |
| Q2 2020 | $5,736,000 | +150.0% | 38,782 | +90.4% | 2.40% | +103.8% |
| Q1 2020 | $2,294,000 | +96.1% | 20,369 | +142.3% | 1.18% | +159.5% |
| Q4 2019 | $1,170,000 | -5.9% | 8,407 | -34.9% | 0.45% | -14.3% |
| Q3 2019 | $1,243,000 | +28.4% | 12,907 | +53.5% | 0.53% | +27.7% |
| Q2 2019 | $968,000 | +134.4% | 8,407 | +139.7% | 0.42% | +121.9% |
| Q1 2019 | $413,000 | – | 3,507 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |